Reimer; Ulf
Patent Applications and Registrations
Patent applications and USPTO patent grants for Reimer; Ulf.The latest application filed is for "peptide mimotopes of claudin 18.2 and uses thereof".
- Reimer; Ulf - Berlin DE
| Patent | Date |
|---|---|
| Peptide mimotopes of the CD3 T-cell co-receptor epsilon chain and uses thereof Grant 11,046,745 - Sahin , et al. June 29, 2 | 2021-06-29 |
| TFPI inhibitors and methods of use Grant 11,001,613 - Dockal , et al. May 11, 2 | 2021-05-11 |
| Peptide mimotopes of claudin 18.2 and uses thereof Grant 10,858,415 - Sahin , et al. December 8, 2 | 2020-12-08 |
| Peptide Mimotopes Of Claudin 18.2 And Uses Thereof App 20200031898 - Sahin; Ugur ; et al. | 2020-01-30 |
| Peptide Mimotopes Of The Cd3 T-cell Co-receptor Epsilon Chain And Uses Thereof App 20190070248 - Sahin; Ugur ; et al. | 2019-03-07 |
| NPR-B agonists Grant 10,196,423 - Osterkamp , et al. Fe | 2019-02-05 |
| NPR-B Agonists App 20180334477 - Osterkamp; Frank ; et al. | 2018-11-22 |
| NPR-B agonists Grant 9,982,016 - Osterkamp , et al. May 29, 2 | 2018-05-29 |
| Tfpi Inhibitors And Methods Of Use App 20180072784 - DOCKAL; Michael ; et al. | 2018-03-15 |
| NPR-B Agonists App 20170313743 - Osterkamp; Frank ; et al. | 2017-11-02 |
| TFPI inhibitors and methods of use Grant 9,777,051 - Dockal , et al. October 3, 2 | 2017-10-03 |
| NPR-B agonists Grant 9,745,344 - Osterkamp , et al. August 29, 2 | 2017-08-29 |
| Peptide Mimotopes Of Claudin 18.2 And Uses Thereof App 20160347815 - Sahin; Ugur ; et al. | 2016-12-01 |
| Cyclic peptide-based NPR-B agonists Grant 9,458,198 - Osterkamp , et al. October 4, 2 | 2016-10-04 |
| Novel NPR-B Agonists App 20160194357 - Ostercamp; Frank ; et al. | 2016-07-07 |
| Ebv Proteins As Markers In Methods Of Diagnosing Chronic Fatigue Syndrome (cfs) App 20160153994 - Scheibenbogen; Carmen ; et al. | 2016-06-02 |
| NPR-B agonists Grant 9,169,293 - Osterkamp , et al. October 27, 2 | 2015-10-27 |
| Novel Npr-b Agonists App 20130345394 - Osterkamp; Frank ; et al. | 2013-12-26 |
| Tfpi Inhibitors And Methods Of Use App 20130274193 - Dockal; Michael ; et al. | 2013-10-17 |
| NPR-B agonists Grant 8,546,523 - Osterkamp , et al. October 1, 2 | 2013-10-01 |
| TFPI inhibitors and methods of use Grant 8,466,108 - Dockal , et al. June 18, 2 | 2013-06-18 |
| 8-oxy-quinoline derivatives as bradykinin B2 receptor modulators Grant 8,410,134 - Gibson , et al. April 2, 2 | 2013-04-02 |
| Method for determining the substrate specificity of an enzyme Grant 8,029,979 - Schneider-Mergener , et al. October 4, 2 | 2011-10-04 |
| Novel Npr-b Agonists App 20110077381 - Osterkamp; Frank ; et al. | 2011-03-31 |
| 8-oxy-quinoline Derivatives As Bradykinin B2 Receptor Modulators App 20100234344 - Gibson; Christoph ; et al. | 2010-09-16 |
| Tfpi Inhibitors And Methods Of Use App 20100173847 - Dockal; Michael ; et al. | 2010-07-08 |
| Method for determining the substrate specificity of an enzymatic activity and a device therefor App 20060234308 - Schneider-Mergener; Jens ; et al. | 2006-10-19 |
| Method for determining the substrate specificity of an enzymatic activity and a device therefor App 20040171097 - Schneider-Mergener, Jens ; et al. | 2004-09-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 